Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hidden threat: hepatitis e may linger in transplant patients

NCT ID NCT02190253

First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 34 times

Summary

This study looked at how many organ transplant recipients have been exposed to the hepatitis E virus. Researchers tested blood from 447 adults who had a liver, kidney, or small bowel transplant, or were waiting for one. The goal was to find out if hepatitis E is a hidden problem in U.S. transplant patients, since it can become a long-term infection in people with weakened immune systems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATITIS E are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Georgetown University

    Washington D.C., District of Columbia, 20007-2197, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104-6056, United States

  • University of Wisconsin

    Madison, Wisconsin, 53792, United States

Conditions

Explore the condition pages connected to this study.